Introduction
The electronic nicotine delivery system, commonly called electronic cigarette or e-cigarette (EC), is a plastic device that was designed to imitate a regular cigarette and to deliver a nicotinecontaining aerosol when puffed by the user. ECs have gained popularity around the world. They are mostly promoted via the Internet but recently also by the entertainment industry. They are available through online stores or retail outlets such as 
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some users since their use is more cost-effective than nonrefi llable cartridges. These solutions are also available in a similar range of fl avors and concentrations of nicotine.
There is some inconsistency in existing data regarding the effi cacy of ECs as nicotine delivery devices. The U . S . FDA evaluated two brands of EC for nicotine content. Nicotine was detected in both products for all cartridges labeled as containing low, medium , and high levels of nicotine. The sparging apparatus was used to quantify the amount of nicotine released during use of these devices. Levels found were consistent with the labeling (low, medium , and high); however, the cartridge labeled " no nicotine " still delivered some nicotine ( Westenberger, 2009 ) . Another study also found nicotine in cartridges labeled as containing no nicotine ( Hadwiger et al., 2010 ) .
Although nicotine seems to be present in ECs, it might not be delivered effectively to the blood stream. Three human studies found no or negligible increases in nicotine blood levels after acute use of EC in naïve users , but it has been also shown that using some brands of EC alleviates nicotine craving ( Bullen et al. 2010 ; Eissenberg, 2010 ; Vansickel, Cobb, Weaver, & Eissenberg, 2010 ) . One study found substantial amounts of cotinine, a metabolite of nicotine, in the saliva of EC users suggesting that experience with the device is likely to infl uence blood nicotine levels .
There are at least three important factors that determine the effi cacy of nicotine delivery from EC to the body. The fi rst is the nicotine content of a cartridge. Puffi ng an EC with high nicotine levels should lead to inhalation of higher doses of the drug. Second is the effi cacy of the vaporization process that determines how much nicotine is actually transferred from a cartridge into the aerosol. Finally, bioavailability of nicotine from the EC aerosol is a key factor, since it limits the amount of inhaled nicotine that is absorbed into the blood stream and reaches the nicotinic receptors in the brain. This study was designed to explore the fi rst two of the above factors by measuring nicotine levels in cartridges and refi ll solutions and evaluating the nicotine vaporization effi cacy of various models of EC brands.
Materials and Methods

EC, Cartridges, and N icotine Refi ll Solutions
We decided to study the most popular brands of ECs available in domestic, European, and U . S . markets. Since the Internet seems to be the main distribution channel for these products, we browsed google . com and google . pl web search engines, price comparison websites, online marketplaces , and Internet discussion forums for EC users and identifi ed 30 popular brands of ECs. We ranked them based on numbers of records in web search engines and chose the 15 brands with the highest number of records. Only one model was chosen per brand, except for the brand Janty, for which we decided to test two popular models (eGo and Dura). The characteristics of ECs evaluated in the study are provided in Table 1 , and all products are presented in Supplementary Figure 1 .
All products were purchased from commercial sources. Eleven ECs were purchased from Polish online shops, four from U . K .-based services, and one from a U . S . online shop. All brand names were removed from the products , and each product was randomly assigned a code to blind lab technicians to the brand tested.
Cartridges and refi ll solutions were purchased from the same sources to ensure they were compatible with tested ECs. In order to achieve variability of the products, we decided to test 20 cartridges and 15 nicotine refi ll solutions. Since they came with various strengths and aromas, there were additional cartridges and refi ll solution that were not part of the 16 chosen ECs. Characteristics of cartridges and nicotine refi ll solutions evaluated in the study are provided in Table 2 , and all cartridges are presented in Supplementary Figure 2 .
We paired each tested EC with cartridges of the same brand name and from the same batch and series, that is, the cartridges were from the same packaging box of the same brand and model and have the same nicotine content and fl avor according to their manufacturer. Total of six cartridges were used for test , three unused cartridges were used to measure nicotine content and three original cartridges were used for EC testing.
Nicotine Aerosol Generation From EC
Aerosol from ECs was generated using smoking machine " Palaczbot " (Technical University of Lodz, Poland) designed for the purpose of this study. This is a one-port linear pistonlike smoking machine with adjustable puffi ng regimes in a very wide range, controlled by computer software. Test conditions were determined to refl ect real-life puffi ng patterns of EC users. We recruited 10 volunteers (aged 35 ± 20 years, 8 males) who used various brands and models of EC for at least one month and measured their puffi ng topography with modifi ed and calibrated CressMicro monitors (Borgwaldt Ltd . , Germany). The average puffi ng topography was as follows ( M ± SD ): puff duration of 1.8 ± 0.9 s, intervals between puffs of 10 ± 13 s, puff volume 70 ± 68 ml, and number of puffs taken in one puffi ng session was 15 ± 6. All testing procedures in this work were carried out using the same averaged puffi ng conditions. A total of 300 puffs were taken from each EC in 20 series of 15 puffs with intervals between series of 5 min each. Each EC was tested three times on 3 following days after batteries were recharged during nights.
Nicotine Analysis in EC Aerosol
Nicotine from EC aerosol was absorbed using liquid extraction to organic solvent technique. EC was connected with short Tefl on pipes with a set of two 200-ml gas washing bottles with coarse spargers. Each washing bottle contained 50 ml of methanol with quinoline as an internal standard (10 μ g/ml). Both washing bottles were immersed in acetone -dry ice bath in order to avoid any losses of volatile solvent. A picture of set for vapor generation from EC and nicotine absorption is presented in Supplementary Figure 3 .
Samples of 0.25 ml were collected from each washing bottle every 15 puffs, with a total of 150 puffs, and every 30 puffs with a total of 300 puffs. A total of 30 samples were collected during each testing procedure for each EC.
Nicotine was analyzed using gas chromatography method with Thermionic Specifi c Detector (GC-TSD, Varian Inc.). We modifi ed the standard NIOSH 2551 method for determination of nicotine in air ( National Institute for Occupational Safety and Health, 1998 ). CP-Sil 8CB, 25 m × 0.25 mm × 0 . 39 mm (1 . 2 μ m ; Varian Note . All results are M ± SE ( n = 3). Values in brackets are percentages of nicotine levels measured in original unused cartridges.
a Levels of nicotine released with 300 puffs were calculated as differences between mean amount of nicotine in original cartridges of the same type and brand and nicotine amounts in used cartridges removed from EC after 300 puffs .
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Inc.) capillary column with fl ow rate of helium of 2.4 ml/min were used . Temperature of injector and detector was 300 °C, column temperature increased from 60 to 200 °C (20 °C/min) and hold for 5 min. Injection volume was 1 μ l, and quinoline was used as an internal standard. Calibration curve was generated to cover the range of nicotine concentration from 0.5 to 50 μ g/ml, which corresponds to cumulative nicotine levels in EC aerosol from 0.2 to 20 mg. The method was validated as per the International Conference on Harmonization guideline Q2 (R1 ; ICH, 2005 ) . Precision of the method was 18%, and quantitation limit was 0.05 μ g/ml. Exemplary chromatogram of the analyzed sample is presented in Supplementary Figure 4 .
Nicotine Analysis in Cartridges and Refi ll Solutions
Nicotine was analyzed in three cartridges of the same batch and series, taken from one box of each brand included in the study. Moreover, nicotine was also analyzed in used cartridges after 300 puffs were taken in the experiments described above. Knowing the amounts of nicotine in the original and used cartridges, it was possible to estimate how much nicotine was released to vapor. Measured amounts of nicotine in original/unused cartridges were also compared with values declared by manufacturers and retailers on their packages. One -sample t test. n/a=not available (information not indicated directly on packages) .
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After gently removing a cartridge from its package, it was placed in a glass 200-ml fl ask and 50 ml of ethyl acetate was added along with 100-μ l internal standard solution (quinoline 50 mg/ml in methanol). The fl ask was covered with parafi lm and placed in an ultrasound bath. After 30 min, 1 ml of the extract was collected and analyzed with the chromatography method described above. Three cartridges of each model were tested. Calibration solutions of nicotine in propylene glycol with a concentration range of 0.01 -40 mg/ml were prepared by weighting proper nicotine amounts and dissolving them in solvent. Calibration and control cartridges were prepared by spiking empty cartridges with 0.5 ml of calibration solution. The whole analytical procedure was then performed to calibrate and validate the method ( ICH, 2005 ) . Precision of the method was 15%, recovery of 98%, and quantitation limit was 0.1 mg/cartridge.
In order to analyze nicotine in refi ll solutions, samples of 100 μ l of each examined solution were diluted with 10 ml methanol, and after adding internal standard (100 μ l quinoline solution 50mg/ml in methanol), were vigorously shaken for 10 min and analyzed as described above. Three samples of each refi ll solution model were tested. To calibrate and validate the method, the same nicotine solutions as described above for the cartridges procedure were used. Precision of the method was 17%, recovery of 102%, and quantitation limit was 0.05 mg/ml.
Statistical Analysis
For each analyzed EC, a nicotine delivery profi le was generated. The profi les represent the relationship between cumulative dose of nicotine released from a cartridge to aerosol and number of puffs. Each point represents M values from three test runs whereas bars correspond to the values of SE s . Differences in nicotine amounts released to aerosol among analyzed ECs were compared using nonparametric ANOVA with Tukey test for comparisons. Measured amounts of nicotine in original cartridges were compared with values declared on their packages using one-sample t test. For all tests Statistica 6.0 (Statsoft) software was used.
Results
Levels of Nicotine in EC Aerosol
Aerosol was visibly being produced during the full 300 puffs taken from each product tested. Results are presented as absolute values in mg of nicotine but also as percentages of nicotine levels measured in original unused cartridges. Absolute and relative levels of nicotine released with 150 and 300 puffs of the examined ECs are summarized in Table 1 . Absolute and relative levels of nicotine released with 300 puffs were also calculated as differences between mean nicotine amount in original unused cartridges of the same brand and model and amounts that remained in the cartridge after 300 puffs. Delivery profi les of nicotine from cartridges to vapor for each analyzed ECs are presented in Figure 1 .
Levels of nicotine in vapors released from analyzed ECs with 150 puffs varied from 0.3 ± 0.2 (EC 05) to 8.7 ± 1.0 mg (EC 11) and with 300 puffs from 0.5 ± 0.1 (EC 05) to 15.4 ± 2.1 (EC 11 ; Table 1 ).
Analyzed ECs varied in effi cacy and consistency of nicotine vaporization ( p < .05). For example, EC 11 and EC 16 vaporized nicotine with 300 puffs with a high effi cacy of 85% and 71%, respectively ( Table 1 ) . EC 08, 09, 11, 14, and 16 delivered nicotine from cartridges to vapor consistently throughout 300 puffs (short bars on nicotine delivery profi les represent low standard error [ SE ] values; Figure 1 ). Contrarily, EC 05 was characterized by very low consistency and was very ineffective in nicotine vaporization, delivering to vapor only 31% of the nicotine present in the cartridge ( Table 1 ) .
Levels of Nicotine in Original Cartridges and Refi ll Solutions
Results of the tested cartridges and refi ll nicotine solutions for nicotine content are presented in Table 2 . We found that nicotine amounts in 9 out of 20 of the analyzed cartridges differed by more than 20% from values declared by their manufacturers (CA 03, 04, 06, 08, 09, 10, 12, 13, and 15) . The differences of the same magnitude were detected among 3 out of 15 nicotine refi ll solutions (RS 02, 13, and 14). For some brands, declared amounts of nicotine were the same as those analyzed by us, indicating the manufacturer ' s credibility.
Discussion
Electronic cigarettes are new products available on international markets. They differ not only by brand names, models , and designs but also by technical characteristics. There has not been any comprehensive testing of various brands and models to see how they differ between each other in nicotine delivery. In our study , we analyzed 16 various EC models, chosen based on their popularity, to see if the products effectively exposed their users to signifi cant amounts of nicotine.
There have been some preliminary studies indicating that ECs may expose their users to nicotine. In most of the studies , nicotine was found in cartridge and refi ll solutions but there is no data so far if any nicotine is actually effectively vaporized ( Coulson, 2009 ; Ellicott, 2009 ; Exponent, 2009 ; Kieckbush, 2009 Kieckbush, , 2010 Laugesen, 2008 Laugesen, , 2010 Valance & Ellicot, 2008 ; Westenberger 2009 ). Three published studies with human subjects who used one of the products showed little or no delivery of nicotine to the blood stream, even when products that contained high nicotine levels were used ( Bullen et al., 2010 ; Eissenberg, 2010 ; Vansickel, Cobb, Weaver, & Eissenberg, 2010 ) . One potential factor affecting this might be poor nicotine delivery from cartridges to vapors, resulting in low nicotine levels inhaled by studied subjects.
Based on our preliminary observations , we decided to test products with conditions , which closely refl ect how experienced " EC smokers " use their products. We tested each product using 20 series of 15 puffs. We found that 300 puffs of ECs that contained " high nicotine " cartridges delivered between 0.5 and 15.4 mg of nicotine, whereas EC with cartridges labeled as " low " or " medium " delivered between 0.5 and 3.1 mg of the drug. The effi cacy of nicotine vaporization differed across ECs. Evaluated ECs vaporized 21% to 85% of relative amounts of nicotine present in the cartridges. The high variability in performance properties of ECs was recently reported by Trtchounian, Williams, and Talbot (2010) . They found that EC brands produced aerosols , which varied in density from puff to puff. Our fi ndings seem to Nicotine levels in electronic cigarettes 
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confi rm their hypothesis about not uniform nicotine delivery from ECs.
Nicotine levels from a single puff of 70 ml may be estimated to be between 1.7 and 51.3 μ g. Results of repeated testing of ECs with three different cartridges with the same label (menthol high) by the FDA gave varying results from 26.8 to 43.2 μ g nicotine per 100 ml puff, which is close to the upper levels observed in the present study ( Westenberger, 2009 ) . Despite the fact that we tested products with lower puff volumes than in the FDA study (70 vs. 100 ml), we found high consistency between the results of one product tested in both studies (EC15; 5.0 vs. 5.3 mg nicotine per 150 puffs).
Assuming a series of 15 puffs is equivalent to smoking one cigarette; this allows us to make some dose comparisons. One series of 15 puffs might have delivered 0.025 -0.77 mg nicotine, which is lower than a dose inhaled from one smoked tobacco cigarette (from 1.54 to 2.60 mg ; Djordjevic, Stellman, & Zang, 2000 ) .
By systematically analyzing how much of the nicotine was released from an EC with every 15 puffs, we were able to generate a nicotine delivery profi le for each tested product. Analysis of the profi les indicates that only part of the nicotine present in a cartridge is vaporized and only some of the nicotine from cartridge is inhaled by EC users (on average 50 % -60%). Thus, making conclusions on how much nicotine is inhaled by EC users based on the content in cartridges might lead to overestimation of the effective dose. Improvement of the vaporization effi cacy would make more or even all the nicotine present in a cartridge available for EC users.
Moreover, nicotine delivery profi les provided interesting data on effi cacy of the vaporization process, indicating that most of the nicotine is delivered during the fi rst 150 -180 puffs. Based on this fi nding, potential users of the products should be instructed to replace nicotine cartridge every 150 puffs in order to achieve effective and steady nicotine exposure.
Our results also suggest that some products are inconsistent in delivering nicotine. These products might deliver different levels of nicotine to their users each time they are used even if containing cartridges of the same nicotine content. This fi nding is consistent with the results found in a study by Williams and Talbot (2011) . The authors reported that the ECs they tested lasted for a variable number of puffs, and some variation was found in models within a brand, when different cartridges were used.
We also found signifi cant differences between labeled and true levels of nicotine in cartridges and refi ll solutions. Traces of nicotine were also detected in one of two cartridges labeled as containing no nicotine. These fi ndings indicate that information about nicotine levels provided on product packages may be misleading to customers. In order to sell the best quality products to customers, manufacturers of ECs should develop and implement quality standards for their products and follow good manufacture policy. The authority to independent agencies should be given to control quality of the products available on market.
We presented a preliminary evaluation of 16 ECs, 20 cartridges, and 15 refi ll solutions and our study was not intended to provide an accurate characterization of any particular brand.
There are many potential limitations in the generality and reliability of our fi ndings because of a relatively small number of samples from each product. Further research is needed to investigate if the variability in nicotine delivery is primarily due to brand variability or a combination of brand variability and fl uctuation within brands.
Our study refl ects the early stage of objective research on ECs and raises new questions. First, how high might nicotine levels be if users were instructed to puff them as hard as possible? Puff duration for individuals using ECs in YouTube videos was longer than we used in the study to simulate EC use with smoking machine (4.3 vs. 1.8 s ; Hua, Yip, & Talbot, 2011 ) . Longer puff duration may help EC users compensate for the poor delivery of nicotine from ECs. Second, what is the prime site of nicotine absorption from EC? Does nicotine from EC reach blood stream via buccal mucosa only ? or is there any lung absorption? Substantial amounts of cotinine, a metabolite of nicotine, found in the saliva of EC users suggest that experience with the device is likely to infl uence blood nicotine levels . Finally, can ECs produce the arterial plasma spikes refl ecting substantial lung delivery as have been shown with tobacco cigarettes?
Supplementary Material
Supplementary Figures 1 -4 can be found online at http :// www . ntr . oxfordjournals . org
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